Bladder Cancer

A pilot study of [18F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy. April 23, 2025

Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients. April 23, 2025

New insights and emerging approaches in bladder-sparing treatment for muscle-invasive bladder cancer. April 23, 2025

A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer. April 22, 2025

Circulating Tumor DNA and Response to Cisplatin-based Chemotherapy in Patients with Metastatic Urothelial Carcinoma Enrolled in CALGB 90601 (Alliance). April 22, 2025

Long-Term Outcomes of Robot-Assisted Radical Cystectomy in Patients with Non-Muscle-Invasive Bladder Cancer - Expert Commentary April 21, 2025

On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC. April 21, 2025

Robot-assisted tubeless radical cystectomy: Is the absence of ureteral drainage a mistake? April 21, 2025

Cost-effectiveness of de-escalated molecular subtype dependent use of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer in a Swedish setting. April 18, 2025

The impact of treatment for muscle-invasive bladder cancer on health-related quality of life. April 18, 2025

Perioperative outcomes using template mapping after radical cystectomy and extended lymph node dissection. April 17, 2025

Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation. April 17, 2025

Performance Large Language Models in Guiding Bladder Cancer Management - Expert Commentary April 16, 2025

Does Neoadjuvant Chemotherapy Followed by Radical Cystectomy Improve the Survival of Muscle-Invasive Bladder Cancer in Real-World Clinical Practice? April 16, 2025

Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers. April 16, 2025

ImmunityBio Announces FDA Submissions of Supplemental BLA for NMIBC Papillary Disease and for Expanded Access of ANKTIVA® to Treat Lymphopenia April 15, 2025

Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancer. April 15, 2025

Integration and evaluation of implementation strategies to improve guideline-concordant bladder cancer surveillance: a prospective observational study. April 15, 2025

A Deep Learning Model to Predict Treatment Response and Recurrence from Whole Slide Images in Non-Muscle-Invasive Bladder Cancer - Expert Commentary April 14, 2025

Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance. April 14, 2025

Page 1 of 535